Founding offer · lifetime membership for a single £24, exclusive to our first members · closes 20 June Claim your place →
Global Research Partnerships £24 Lifetime Log inCreate free account

Funded Projects › FP7

HUMAN · Health and the Understanding of Metabolism, Aging and Nutrition

FP7Status: CLOSED1 October 201330 September 2018EU funding €11,994,553

Recently intense research identified around 4,000 single nucleotide polymorphisms (SNPs) associated with human age related diseases such as metabolic disorders. Despite their highly significant association to pathology, the functional role of these genetic variants is, in most cases, yet to be elucidated. The evolutionary distance of most animal models from humans represents a major limitation for the functional validation of these SNPs. To overcome these difficulties, HUMAN will generate mouse models carrying human hepatocytes or pancreatic βcells from either primary cells (hepatocytes) or induced pluripotent stem cells (iPSCs). This innovative approach offers the unique possibility of studying function of genetic risk variants associated with metabolic diseases in an integrated living system (the mouse body), but within human-derived organs, i.e. liver and pancreas. iPSCs used to generate hepatocytes and βcells will derive from extreme phenotypes, i.e. patients affected by severe metabolic diseases such as type 2 diabetes (T2D) or subjects selected for exceptional healthy longevity (subjects over 105 years and offspring of nonagenarian sibships) all fully clinically and metabolically characterised and genotyped; they will be selected according to the best combination of risk and protective alleles. We will test the effect of different nutritional regimes (e.g. high fat diet, caloric restriction), to disentangle the complex molecular mechanisms and circuitry across organs (e.g. hypothalamus-liver axis) which lead to pathology. HUMAN associates a core of outstanding basic research institutions to leading European biotech SMEs, and has the capability to produce at least 500 humanised mice. HUMAN will generate iPSCs biobanks and comprehensively manage all associated information. HUMAN is uniquely situated to drive innovation towards a better knowledge of the genetic basis of human metabolic diseases, thereby contributing to healthier aging of European citizens.

Consortium · 16 organisations

coordinator

KAROLINSKA INSTITUTET

SE · €4,027,080

participant

ACADEMISCH ZIEKENHUIS LEIDEN

NL · €412,750

participant

Université Paris Diderot-Paris 7

FR · €523,000

participant

EUROFINS GENOMICS EUROPE PHARMA AND DIAGNOSTICS PRODUCTS & SERVICES SANGER PCR GMBH

DE · €749,749

participant

GENEDATA AG

CH · €746,748

participant

AcureOmics AB

SE · €683,650

participant

NESTEC SA

CH · €728,000

participant

ACURE PHARMA AB

SE

participant

UNIVERSITA DEGLI STUDI DI MILANO

IT · €397,000

participant

ALMA MATER STUDIORUM - UNIVERSITA DI BOLOGNA

IT · €514,000

participant

YECURIS CORPORATION FOR PROFIT CORPORATION

US · €1,404,660

participant

UNIVERSITY COLLEGE LONDON

€615,116

participant

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS

FR · €574,500

participant

PRONEXUS ANALYTICAL AB

SE · €200,565

participant

THE UNIVERSITY OF EDINBURGH

UK · €234,575

participant

KING'S COLLEGE LONDON

UK · €183,160

Research fields

View the official record on CORDIS →

← Find collaborators and more funded projects

Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.